Contravisory Investment Management, Inc. Incyte Corp Transaction History
Contravisory Investment Management, Inc.
- $483 Million
- Q2 2025
A detailed history of Contravisory Investment Management, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 11,338 shares of INCY stock, worth $886,631. This represents 0.16% of its overall portfolio holdings.
Number of Shares
11,338
Previous 11,365
0.24%
Holding current value
$886,631
Previous $688,000
12.21%
% of portfolio
0.16%
Previous 0.15%
Shares
11 transactions
Others Institutions Holding INCY
# of Institutions
706Shares Held
194MCall Options Held
564KPut Options Held
317K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.4 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.67 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.56 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.16 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$785 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $17.4B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...